Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Breast 1

Conditions

Prostatic Neoplasms 185Breast Neoplasms 27Neoplasms 13Leiomyoma 11Polycystic Ovary Syndrome 5Neoplasm Metastasis 4Salivary Gland Neoplasms 3Prostate Adenocarcinoma 3Multiple Myeloma 3Lymphoma, Non-Hodgkin 3Adenocarcinoma 3Rare Diseases 2Premenopausal Breast Cancer 2Myofibroma 2Myelodysplastic Syndromes 2Leukemia, Myeloid, Acute 2Hodgkin Disease 2Breast Neoplasms, Male 2Uveal Melanoma 1Uterine Neoplasms 1Urogenital Neoplasms 1Stage I Prostate Adenocarcinoma AJCC v7 1Sleep Apnea, Obstructive 1Skin Neoplasms 1Skin Diseases 1Sexual Dysfunctions, Psychological 1Sexual Dysfunction, Physiological 1Salivary Gland Neoplasm Duct 1Respiratory Tract Diseases 1Recurrence 1

Interventions

Exercise 3Patient Navigation 2Interviews as Topic 2Anastrozole 2regorafenib 1potassium oxonate 1beta-Aminoethyl Isothiourea 1Weights and Measures 1Videotape Recording 1Trastuzumab 1Surveys and Questionnaires 1Standard of Care 1Specimen Handling 1Self Care 1Radiation 1Psychosocial Intervention 1Oxaliplatin 1Ocoxin 1Nutrition Assessment 1N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine 1Motivational Interviewing 1Metabolism 1Leuprolide 1Lapatinib 1Goserelin 1Diet Therapy 1Diet 1Clodronic Acid 1Cisplatin 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Patient Compliance × Leuprolide × Clear all
NCT05122377 2026-01-06

RWE About QOL and Compliance of Patients With OFS in China

Fudan University

Completed
562 enrolled
Breast

Breast Neoplasms, Patient Compliance

Data powered by HemOnc (CC BY 4.0) Colophon âš¡